tradmap

NTRB NutriBand Inc.

$6.29 +1.04%

Data as of close

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

NutriBand Inc. (NTRB) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $77 million. Shares last traded at $6.29, 33.7% below their 52-week high. Over the past year the stock is down 13.0%. Net profit margin is -430.4%, below the peer median of 5.3%. Revenue declined 4.8% year over year.

Market Cap
$77M
Shares Out
12.2M
EPS (TTM)
-$0.51
P/E (TTM)*
—
P/S Ratio
47.30
P/B Ratio
14.36
Dividend / Share
—
Dividend Yield
—
52-Week High
$9.50
52-Week Low
$2.83
Volume (venue)
445
Avg Vol (3m, venue)
1,259.397

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+3.96%
1M
-16.18%
3M
+112.31%
6M
+61.41%
YTD
+38.35%
1Y
-12.99%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
49.06
SMA (50)
$6.39
SMA (200)
$4.49
Price vs SMA50
-1.48%
Price vs SMA200
+40.26%
ATR (14)
$0.43

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2M
Net Income
-$7M
Gross Margin
33.1%
Operating Margin
-435.6%
Net Margin
-430.4%
Return on Equity
-130.7%
Return on Assets
-110.6%
Current Ratio
4.21
Debt / Equity
0.00
Revenue Growth (YoY)
-4.8%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-07-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2027 -$0.07 2026-09-04
Q1 2027 -$0.10 2026-06-11
Q4 2026 (derived) -$0.02 2026-04-29
FY 2026 -$2.58 2026-04-29
Q3 2026 -$0.32 2025-12-11
Q2 2026 -$2.12 2025-09-09

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

NTRB vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/S vs peers
47.30 / 2.67 med
+1672% premium
Net margin vs peers
-430.4% / 5.3% med
below median
1–14 of 14
ISRGIntuitive Surgical$151.5B51.2313.0825.5%+1.13%
EWEdwards Lifesciences$53.7B53.498.2515.4%+1.35%
STESteris$22.7B28.253.7713.3%+2.70%
ZBHZimmer Biomet$18.6B23.012.189.5%+2.98%
ALGNAlign Technology$11.0B26.482.6510.0%+2.86%
MSAMsa Safety Inc$7.2B22.983.7116.1%+4.76%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.40-15.8%-2.14%
CDRECadre Holdings, Inc.$1.4B37.461.975.3%+4.02%
ENOVEnovis Corp$1.2B—0.52-48.0%+3.51%
AVRAnteris Technologies Global Corp.$562M—250.82—-8.63%
SMTISanara MedTech Inc.$296M—2.69-29.2%-1.98%
INGNInogen Inc$182M—0.60-8.1%+0.00%
LAKELAKELAND INDUSTRIES INC$89M—0.47-14.0%+1.24%
NTRBNutriBand Inc.$77M———+1.04%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.